Clinical Trial Update: Vitamin D and Vitamin B12 Supplementation With Pegylated Interferon-Alfa Plus Ribavirin for Treating Chronic Hepatitis C [Phase 4]

View source ↗

Summary

Phase 4 trial assessing whether adding vitamin D and vitamin B12 to pegylated interferon-alfa plus ribavirin improves outcomes in chronic hepatitis C. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Copegus (ribavirin)
• Pegasys (pegylated interferon alfa-2a)
• Ribavirin (ribavirin)
• Vitamin B12 (cobalamin)
• Vitamin D (Cholecalciferol)

Snippet

Sponsor: Federal University of São Paulo | Conditions: RNA Virus Infections, Flaviviridae Infections | Phase 4 | Status: TERMINATED